Log in
16.05.2025

Deal |

2025

TILT Biotherapeutics raised $25.6M to find a cure for ovarian cancer

  • HQ: FI

Founded: 2013

  • Series B
  • Sector: Health Care

Investment Raised: USD 25.6m €

Valuation Remains Undisclosed

Investors: European Innovation Council, Lifeline Ventures, Stephen Industries, Tesi

News Link
05.05.2025

Deal of the Week |

Calendar Week # 18 |

2025

SafeHeal Closes Oversubscribed €35 Million Series C Equity Financing

  • HQ: FR

Founded: 2015

  • Series C
  • Sector: Health Care

Investment Raised: EUR 35M €

Valuation Remains Undisclosed

Investors: Solar Eclipse, Sofinnova Partners, M&L Healthcare Investments, Gideon Strategic Partners

News Link
04.04.2025

Deal |

2025

CMR Surgical secures more than $200M to accelerate growth

  • HQ: UK

Founded: 2014

  • Funding Round
  • Sector: Health Care

Investment Raised: USD 200m €

Valuation Remains Undisclosed

Investors: Trinity Capital

News Link
27.03.2025

Deal |

2025

Carlyle provides €250m strategic capital for Sanoptis

  • HQ: CH

Founded: 2018

  • Private Equity
  • Sector: Health Care

Investment Raised: EUR 250m €

Valuation Remains Undisclosed

Investors: The Carlyle Group

News Link
07.03.2025

Deal |

2025

Carlyle and Arcmont provide €470 million financing package to Bianalisi

  • HQ: IT

Founded: 1968

  • Private Equity
  • Sector: Health Care

Investment Raised: EUR 470m €

Valuation Remains Undisclosed

Investors: Arcmont Asset Management, Natixis, The Carlyle Group

News Link
27.02.2025

Deal |

2025

OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital

  • HQ: UK

Founded: 2008

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: USD 142m €

Valuation Remains Undisclosed

Investors: Avidity Partners, Business Growth Fund, HealthQuest Capital, Lauxera Capital Partners, Longwall Venture, Oxford Technology Management, Sofina, Soleus Capital, Technikos, University of Oxford

News Link
12.02.2025

Deal |

2025

Avelios nabs $31M led by Sequoia to fix the ailing world of healthcare IT

  • HQ: DE

Founded: 2020

  • Series A
  • Sector: Health Care

Investment Raised: EUR 30m €

Valuation Remains Undisclosed

Investors: HTGF | High-Tech Gruenderfonds, Revent, Sequoia Capital

News Link
13.01.2025

Deal of the Week |

Calendar Week # 2 |

2025

CeQur secures $120 million to scale diabetes management solutions

  • HQ: CH

Founded: 2008

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: USD 120m €

Valuation Remains Undisclosed

News Link
10.01.2025

Deal |

2025

FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care

  • HQ: IE

Founded: 2013

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: USD 120m €

Valuation Remains Undisclosed

Investors: Andera Partners, Elevage Medical Technologies, Gilde Healthcare, Ireland Strategic Investment Fund, Lightstone Ventures, Longitude Capital, Medtronic, New Enterprise Associates, Novo Holdings, Polaris Partners, Sands Capital Ventures, Seventure Partners

News Link
10.01.2025

Deal |

Calendar Week # 2 |

2025

CeQur secures $120 million to scale diabetes management solutions

  • HQ: CH

Founded: 2008

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: USD 120m €

Valuation Remains Undisclosed

News Link
10.01.2025

Deal |

2025

Novo Holdings Participates in €90 Million Series A Financing Round for Orbis Medicines to Support Development of Oral Macrocycle Drugs

  • HQ: DK

Founded: 2021

  • Series A
  • Sector: Health Care

Investment Raised: EUR 90m €

Valuation Remains Undisclosed

Investors: Cormorant Asset Management, Eli Lilly, Export and Investment Fund, Forbion Capital Partners, New Enterprise Associates, Novo Holdings

News Link
10.01.2025

Deal |

2025

General Atlantic-backed biotech start-up secures $410mn in initial funding round

  • HQ: UK
  • Series A
  • Sector: Health Care

Investment Raised: USD 411m €

Valuation Remains Undisclosed

Investors: Forbion Capital Partners, General Atlantic, Lilly Asia Ventures, Logos Capital, LYFE Capital, OrbiMed, RA Capital Management

News Link
20.12.2024

Deal |

2024

Akamis Bio Announces $60 Million in Funding Linked to Series A Prime Financing and New Strategic Partnership

  • HQ: UK

Founded: 2010

  • Series A
  • Sector: Health Care

Investment Raised: USD 60m €

Valuation Remains Undisclosed

Investors: Sedgwick Yard

News Link
22.11.2024

Deal |

2024

Oura valued at $5B following deal with medical device firm Dexcom

  • HQ: FI

Founded: 2013

  • Series D
  • Sector: Health Care

Investment Raised: USD 75m €

USD 4.9b

Valuation

Investors: Dexcom

News Link
22.11.2024

Deal |

2024

Quanta Dialysis Technologies Closes Over $60M Series E Funding

  • HQ: UK

Founded: 2008

  • Series E
  • Sector: Health Care

Investment Raised: USD 60m €

Valuation Remains Undisclosed

Investors: b2venture, Glenview Capital Management, Novo Holdings

News Link
07.11.2024

Deal |

2024

Stockholm-based Yazen Health secures €19.5 million to combat obesity

  • HQ: SE

Founded: 2021

  • Series A
  • Sector: Health Care

Investment Raised: EUR 19.5m €

Valuation Remains Undisclosed

Investors: Aggregate Media, Almaz Capital, Evli Growth Partners, Helsana HealthInvest, Luminar Ventures, Yabeo

News Link
30.10.2024

Deal |

2024

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

  • HQ: DE

Founded: 2018

  • Series B
  • Sector: Health Care

Investment Raised: USD 34m €

Valuation Remains Undisclosed

Investors: ATHOS, Boehringer Ingelheim Venture Fund, Carma Fund, HTGF | High-Tech Gruenderfonds, IBB Ventures, Mayo Clinic, Wellington Partners

News Link
04.10.2024

Deal |

2024

Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens

  • HQ: UK

Founded: 2016

  • Series B
  • Sector: Health Care

Investment Raised: USD 32.5m €

Valuation Remains Undisclosed

Investors: M Ventures, Pfizer Venture Investments, RA Capital Management, Samsara BioCapital, SV Health Investors, The Francis Crick Institute

News Link
30.09.2024

Deal of the Month |

September |

2024

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

  • HQ: BE

Founded: 2022

  • Series A
  • Sector: Health Care

Investment Raised: EUR 93m €

Valuation Remains Undisclosed

Investors: EQT Life Sciences, Eurazeo, Ion Beam Applications, Korys, Kurma Partners, Paladin, PMV, SFPIM

News Link
20.09.2024

Deal |

2024

Neo Medical Secures Landmark Equity Investment of $68 million to Accelerate Global Growth in Spine Surgery

  • HQ: CH

Founded: 2013

  • Series B
  • Sector: Health Care

Investment Raised: CHF 58m €

Valuation Remains Undisclosed

Investors: Gyrus Capital, Jonas Larsson, Vincent Lefauconnier

News Link
20.09.2024

Deal |

2024

Global VC deals for September 17, 2024

  • HQ: UK

Founded: 2018

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: GBP 29.2m €

Valuation Remains Undisclosed

Investors: Cherry Ventures, Felix Capital, Octopus Ventures

News Link
13.09.2024

Deal of the Week |

Calendar Week # 37 |

2024

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

  • HQ: BE

Founded: 2022

  • Series A
  • Sector: Health Care

Investment Raised: EUR 93m €

Valuation Remains Undisclosed

Investors: EQT Life Sciences, Eurazeo, Ion Beam Applications, Korys, Kurma Partners, Paladin, PMV, SFPIM

News Link
06.09.2024

Deal |

2024

Doccla bags £35M for European expansion

  • HQ: UK

Founded: 2019

  • Series B
  • Sector: Health Care

Investment Raised: GBP 35m €

Valuation Remains Undisclosed

Investors: Bertelsmann Investments, Elaia, General Catalyst, Lakestar, Speedinvest

News Link
25.07.2024

Deal |

2024

TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones

  • HQ: FR

Founded: 2013

  • Series D
  • Sector: Health Care, Medical, Medical Device

Investment Raised: EUR 46M €

Valuation Remains Undisclosed

News Link
16.07.2024

Deal |

2024

Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing

  • HQ: DE

Founded: 2016

  • Series D
  • Sector: Biotechnology, Health Care, Medical, Therapeutics

Investment Raised: EUR 150M €

Valuation Remains Undisclosed

Investors: Vesalius Biocapital Partners, Omega Funds, Novartis, Jeito Capital, Gilde Healthcare, Forbion Capital Partners, Canaan Partners, Brandon Capital, Bioqube Ventures

News Link
08.07.2024

Deal |

2024

SmartCella raises EUR 50 million to accelerate growth and commercialization

  • HQ: SW

Founded: 2014

  • Private Equity Round
  • Sector: Biotechnology, Health Care, Life Science, Medical, Therapeutics

Investment Raised: EUR 50M €

EUR 500M

Valuation

Investors: SEB (Skandinaviska Enskilda Banken), RoosGruppen, Handelsbanken Fonder, Fjarde AP-fonden, AstraZeneca, AMF

News Link
27.05.2024

Deal |

2024

Spectrum.Life closes €17m funding round to bolster growth

  • HQ: IE

Founded: 2018

  • Series B
  • Sector: Health Care

Investment Raised: EUR 17M €

Valuation Remains Undisclosed

Investors: Act Venture Capital

News Link
26.03.2024

Deal |

2024

Protembis raise €30M Series B for heart surgery device

  • HQ: DE

Founded: 2013

  • Series B
  • Sector: Health Care

Investment Raised: EUR 30M €

Valuation Remains Undisclosed

Investors: coparion (https://www.coparion.vc/en) Segulah Medical Acceleration (https://segulahmedical.com/) TechVision Fund (https://www.techvision-fonds.de/) XGEN Venture (https://xgenventure.com/)

News Link
26.03.2024

Deal |

2024

Porto-based health tech Tonic App raises €10.85 million Series A to enter the UK and Germany

  • HQ: PT

Founded: 2016

  • Series A
  • Sector: Health Care

Investment Raised: EUR 10.85M €

Valuation Remains Undisclosed

Investors: Vesalius Biocapital Partners (http://www.vesaliusbiocapital.com/) Shilling (https://www.shilling.vc/) Portugal Ventures (http://www.portugalventures.pt/) Iberis Capital (https://iberiscapital.com/) FSNB Health & Care (https://www.fsnb.eu/) BlueCrow Capital (https://www.bluecrowcapital.com/) Armilar Venture Partners.

News Link
14.03.2024

Deal |

2024

Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline

  • HQ: DE

Founded: 2012

  • Series B
  • Sector: Health Care

Investment Raised: EUR 128M €

Valuation Remains Undisclosed

Investors: Andera Partners (http://www.anderapartners.com/en/) Bayern Kapital (http://bayernkapital.de) BioMedPartners (http://www.biomedvc.com) coparion (http://www.coparion.vc/en) Deep Track Capital (http://www.deeptrackcapital.com) EQT life science (http://www.lspvc.com) Evotec (http://evotec.com) Frazier Life Sciences (http://frazierls.com) Fund+ (http://fundplus.be/) High-Tech Grunderfonds (http://www.htgf.de) Nextech Invest (http://www.nextechinvest.com) OCCIDENT (http://www.occident.group) Seventure Partners (http://www.seventure.fr)

News Link